WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007012439) PHARMACEUTICAL COMPOSITIONS COMPRISING LEVETIRACETAM AND PROCESS FOR THEIR PREPARATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/012439    International Application No.:    PCT/EP2006/007260
Publication Date: 01.02.2007 International Filing Date: 24.07.2006
IPC:
A61K 9/20 (2006.01), A61K 9/36 (2006.01), A61K 31/4015 (2006.01), A61P 25/08 (2006.01)
Applicants: UCB PHARMA, S.A. [BE/BE]; 60, Allée de la Recherche, B-1070 Brussels (BE) (For All Designated States Except US).
DELEERS, Michel [BE/BE]; (BE) (For US Only).
HUBERT, Jean-Benoît [BE/BE]; (BE) (For US Only)
Inventors: DELEERS, Michel; (BE).
HUBERT, Jean-Benoît; (BE)
Common
Representative:
UCB INTELLECTUAL PROPERTY; c/o UCB S.A., Allée de la Recherche 60, B-1070 Brussels (BE)
Priority Data:
05016189.2 26.07.2005 EP
05016945.7 04.08.2005 EP
Title (EN) PHARMACEUTICAL COMPOSITIONS COMPRISING LEVETIRACETAM AND PROCESS FOR THEIR PREPARATION
(FR) COMPOSITIONS PHARMACEUTIQUES A BASE DE LEVETIRACETAM ET LEUR METHODE DE PREPARATION
Abstract: front page image
(EN)The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient and 2.0 to 9.0% per weight of disintegrant, 0.0 to 3.0% per weight of gliding agent, 0.5 to 6.0% per weight of binder, and 0.0 to 1.0% per weight of lubricant, with respect to the total weight of the pharmaceutical composition, and to a process for its preparation.
(FR)La présente invention concerne une composition pharmaceutique qui comprend le lévétiracétam comme principe actif et 2,0 à 9,0 % en poids de désintégrant, 0,0 à 3,0 % en poids d'agent de glissement, 0,5 à 6,0 % en poids de liant et 0,0 à 1,0 % en poids de lubrifiant, par rapport au poids total de la composition pharmaceutique, et une méthode pour sa préparation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)